Neurophysiological Biomarkers in Corticobasal Syndrome

Migration, Crosslink

📖

Neurophysiological Biomarkers in Corticobasal Syndrome

active

wiki page Created: 2026-04-02T07:20:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diagnostics-neurophysiological-biom

📖 Wiki Page

diagnostic2751 wordssynced 2026-04-02

Overview

flowchart TD diagnostics_neurophysiological["Neurophysiological Biomarkers in Corticobasal Sy"] style diagnostics_neurophysiological fill:#4fc3f7,stroke:#333,color:#000 diagnostics_neurophy_0["1. Transcranial Magnetic Stimulation TMS Findi"] diagnostics_neurophysiological -->|"includes"| diagnostics_neurophy_0 style diagnostics_neurophy_0 fill:#81c784,stroke:#333,color:#000 diagnostics_neurophy_1["1.1 Motor Cortex Hyperexcitability Pathophysio"] diagnostics_neurophysiological -->|"includes"| diagnostics_neurophy_1 style diagnostics_neurophy_1 fill:#ef5350,stroke:#333,color:#000 diagnostics_neurophy_2["1.2 TMS Parameter Details"] diagnostics_neurophysiological -->|"includes"| diagnostics_neurophy_2 style diagnostics_neurophy_2 fill:#ffd54f,stroke:#333,color:#000 diagnostics_neurophy_3["1.3 TMS in Differential Diagnosis"] diagnostics_neurophysiological -->|"includes"| diagnostics_neurophy_3 style diagnostics_neurophy_3 fill:#ce93d8,stroke:#333,color:#000 diagnostics_neurophy_4["1.4 Advanced TMS Paradigms"] diagnostics_neurophysiological -->|"includes"| diagnostics_neurophy_4 style diagnostics_neurophy_4 fill:#4fc3f7,stroke:#333,color:#000 diagnostics_neurophy_5["1.5 TMS and Disease Progression"] diagnostics_neurophysiological -->|"includes"| diagnostics_neurophy_5 style diagnostics_neurophy_5 fill:#81c784,stroke:#333,color:#000

...

Overview

Mermaid diagram (expand to render)

Neurophysiological biomarkers in [corticobasal syndrome (CBS)](/diseases/corticobasal-syndrome) provide valuable insights into cortical and subcortical dysfunction, offering potential for diagnosis, differential diagnosis, and disease progression monitoring. Unlike imaging biomarkers which provide structural information, neurophysiology captures the functional state of neural circuits, revealing synaptic dysfunction, membrane instability, and network dysconnectivity that precede visible atrophy["@boe2001"].

The characteristic neurophysiological profile of CBS includes severe motor cortex hyperexcitability (reflecting GABAergic dysfunction), asymmetric cortical slowing on EEG, prolonged central motor conduction, and progressive changes over time that mirror clinical deterioration. This profile is distinct from [progressive supranuclear palsy (PSP)](/diseases/progressive-supranuclear-palsy) (moderate hyperexcitability), [Parkinson's disease (PD)](/diseases/parkinsons-disease) (normal excitability), and [amyotrophic lateral sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis) (similar hyperexcitability but with upper motor neuron signs)[@gourdon2023].

1. Transcranial Magnetic Stimulation (TMS) Findings

1.1 Motor Cortex Hyperexcitability — Pathophysiological Basis

One of the most consistent neurophysiological findings in [corticobasal syndrome (CBS)](/diseases/corticobasal-syndrome) is motor cortex hyperexcitability[@chen2024][@kim2024][@cantone2007]. This finding reflects dysfunction of [GABAergic](/mechanisms/gabaergic-dysfunction) inhibitory circuits and is useful in differential diagnosis against [Parkinson's disease (PD)](/diseases/parkinsons-disease) and [progressive supranuclear palsy (PSP)](/diseases/progressive-supranuclear-palsy).

The three classical TMS parameters in CBS show characteristic abnormalities:

| Parameter | Abbreviation | CBS Finding | Physiological Interpretation |
|-----------|-------------|-------------|----------------------------|
| Resting Motor Threshold | RMT | Reduced 10-15% | Increased membrane excitability of corticospinal neurons |
| Short-Interval Intracortical Inhibition | SICI | Severely reduced (often absent) | Loss of GABA-A receptor-mediated intracortical inhibition |
| Cortical Silent Period | CSP | Shortened 30-50% | Reduced GABA-B receptor-mediated recurrent inhibition |

The severity of SICI reduction in CBS exceeds that seen in [PSP](/diseases/progressive-supranuclear-palsy) and far exceeds that in [PD](/diseases/parkinsons-disease), making it one of the most discriminating TMS parameters[@tommasini2022][@priori2001].

1.2 TMS Parameter Details

Short-Interval Intracortical Inhibition (SICI)

SICI is tested by delivering a subthreshold conditioning stimulus (typically 70-80% of RMT) followed 1-5ms later by a suprathreshold test stimulus. In healthy individuals, the conditioning stimulus suppresses the motor evoked potential (MEP) amplitude by 50-80% via GABA-A receptor activation.

In CBS:

SICI is often completely absent (0% inhibition) even at ISIs of 2-3ms
This reflects severe loss of GABAergic basket cells in the motor cortex
The abnormality is more pronounced on the clinically more-affected side
SICI reduction correlates with alien limb phenomena and cortical sensory loss

Differential diagnostic value[@cantone2007]:

| Condition | SICI Level | Clinical Correlation |
|-----------|-----------|---------------------|
| CBS | Absent/severe reduction | Alien limb, apraxia, myoclonus |
| PSP | Moderate reduction | Axial rigidity, supranuclear gaze palsy |
| PD | Normal | Resting tremor, rigidity, bradykinesia |
| CBS-ALS overlap | Absent | Combined CBS + ALS features |

Cortical Silent Period (CSP)

The CSP measures the interruption of voluntary EMG activity following a suprathreshold TMS pulse. In CBS, the CSP is shortened from the normal ~150ms to 60-90ms, reflecting reduced GABA-B receptor-mediated inhibition.

Correlation with clinical features:

Shortened CSP correlates with myoclonus severity
Myoclonic jerks in CBS are associated with cortical hyperexcitability
The CSP shortening is more asymmetric in CBS than in PSP

Resting Motor Threshold (RMT)

While RMT reduction is less specific than SICI, it provides information about membrane-level excitability:

RMT reduction of 10-15% in CBS vs. healthy controls
Reflects increased sodium channel availability at corticospinal neurons
Combined with SICI reduction, provides a dual marker of cortical dysfunction

1.3 TMS in Differential Diagnosis

| TMS Parameter | [CBS](/diseases/corticobasal-syndrome) | [PSP](/diseases/progressive-supranuclear-palsy) | [PD](/diseases/parkinsons-disease) |
|-----------|-----------------------------------------|-----------------------------------------------|-----------------------------------|
| RMT | Reduced 10-15% | Reduced 5-8% | Normal |
| SICI | Severely reduced | Moderately reduced | Normal |
| CSP | Shortened 30-50% | Mildly shortened | Normal |
| CMCT | Prolonged (asymmetric) | Prolonged (symmetric) | Normal |
| MEP amplitude | Increased | Normal to slightly increased | Normal |

The asymmetric pattern of TMS abnormalities in CBS is particularly useful for distinguishing it from PSP, which typically shows more symmetric findings[@kim2024].

1.4 Advanced TMS Paradigms

Theta Burst Stimulation (TBS)

TBS delivers repetitive pulses at 5 Hz (theta frequency) in trains. Intermittent TBS (iTBS) facilitates motor cortex, while continuous TBS (cTBS) inhibits it.

CBS findings:

iTBS-induced facilitation is exaggerated in CBS (reflecting hyperexcitability)
cTBS fails to produce normal inhibition (GABA-B dysfunction)
May serve as a probe for neuroplasticity mechanisms

Paired Associative Stimulation (PAS)

PAS combines peripheral nerve stimulation with TMS over the motor cortex at specific inter-stimulus intervals (typically 25ms, matching N20-P40 latency).

CBS findings:

PAS-induced long-term potentiation (LTP) is impaired
Reflects dysfunction of NMDA receptor-dependent plasticity
Correlates with cognitive impairment and cortical involvement
May explain why rehabilitation approaches have limited efficacy in CBS

TMS-EEG Co-Registration

TMS-EEG records cortical evoked responses following TMS pulses, providing information beyond motor outcomes[@benussi2023].

CBS-specific TMS-EEG findings:

Elevated P30/N45 amplitude (reflecting enhanced short-latency excitation)
Reduced TMS-Evoked Potential (TEP) N100 (GABA-B dysfunction)
Disrupted alpha event-related desynchronization
Abnormal gamma-band oscillations (40-100 Hz) reflecting cortical hyperexcitability

The global mean field power of TMS-EEG responses is significantly elevated in CBS vs. PSP and PD, suggesting widespread cortical dysfunction[@benussi2023].

1.5 TMS and Disease Progression

Longitudinal TMS studies demonstrate progressive changes that mirror clinical deterioration[@wokacket2024]:

SICI decline: Progressive reduction in SICI over 12-24 months correlates with clinical worsening
RMT reduction: Further reduction as disease progresses
CMCT prolongation: Increasing conduction time reflects corticospinal tract degeneration
Side asymmetry: The affected/unaffected side ratio increases as disease advances

Correlation with clinical scales:

SICI reduction correlates with UPDRS-III motor scores
CSP shortening correlates with myoclonus severity
CMCT prolongation correlates with corticospinal weakness

2. Motor Evoked Potentials (MEP)

2.1 Central Motor Conduction Time (CMCT)

MEPs are recorded from target muscles following transcranial magnetic stimulation of the motor cortex. CMCT is calculated by subtracting the peripheral conduction time (from cervical spine to muscle) from the total MEP latency[@sasaki2023][@diLazzaro2012].

Normal values:

CMCT upper limb (APB muscle): 6-8 ms
CMCT lower limb (tibialis anterior): 12-16 ms

In CBS:

Prolonged CMCT in 60-70% of patients (reflecting corticospinal tract involvement)
More pronounced on the clinically affected side (asymmetric involvement)
As disease progresses, CMCT prolongation increases
Can be used to track upper motor neuron involvement over time

2.2 MEP Amplitude and Recruitment

| Parameter | CBS Finding | Interpretation |
|-----------|-------------|----------------|
| Resting MEP amplitude | Increased | Reflects motor cortex hyperexcitability |
| MEP recruitment curve | Left-shifted | Lower stimulus intensity needed for maximal response |
| Stimulus-response curve slope | Steeper | Enhanced corticospinal excitability |
| Contralateral silent period | Shortened | GABA-B dysfunction |

The combination of increased MEP amplitude + shortened CSP is highly characteristic of CBS and differentiates it from PD (normal MEP amplitude, normal CSP) and PSP (intermediate findings)[@marinelli2017].

2.3 Corticospinal Tract Involvement

MEP abnormalities in CBS reflect involvement of the corticospinal pathway:

Cortical level: Hyperexcitable motor cortex neurons

Subcortical white matter: Tau pathology in corticospinal tracts

Brainstem: Secondary degeneration of corticospinal fibers

The asymmetric pattern of CMCT prolongation correlates with:

Asymmetric limb weakness
Primitive reflex release (Babinski sign) on affected side
Myoclonus severity

3. Electroencephalography (EEG) Findings

3.1 Background Rhythm Abnormalities

EEG in [CBS](/diseases/corticobasal-syndrome) shows characteristic patterns that reflect cortical dysfunction[@martinez2023]:

| EEG Finding | CBS Frequency | Normal | Clinical Significance |
|------------|--------------|--------|----------------------|
| Alpha rhythm | 8-10 Hz (slowed) | 10-12 Hz | Cortical dysfunction |
| Theta activity | Elevated (frontal) | Low | Executive dysfunction |
| Delta activity | Elevated (late disease) | Absent | Severe neurodegeneration |
| Asymmetry | Present | Absent | Lateralized cortical involvement |

Key characteristic: Asymmetric background slowing

More pronounced over the affected hemisphere
Often worse in posterior regions on the affected side
Contrasts with PSP's typically symmetric pattern

3.2 Quantitative EEG (qEEG) Analysis

Quantitative EEG provides objective measures of cortical activity[@Leodori2024]:

| qEEG Parameter | CBS Finding | PSP Finding | Clinical Correlation |
|----------------|--------------|-------------|---------------------|
| Alpha power (8-12 Hz) | Severely reduced | Moderately reduced | [Cognitive impairment](/mechanisms/cognitive-decline-neurodegeneration) |
| Theta power (4-8 Hz) | Elevated (frontal) | Diffuse elevation | Disease severity |
| Alpha/theta ratio | Markedly reduced | Reduced | Cognitive decline |
| Beta power (13-30 Hz) | Normal to reduced | Normal | Motor cortex involvement |
| Delta power (0.5-4 Hz) | Elevated (late disease) | Elevated (advanced) | Global dysfunction |

3.3 EEG Connectivity Analysis

Advanced connectivity analysis reveals network-level dysfunction in CBS[@baratelli2021]:

Inter-Hemispheric Connectivity

Reduced inter-hemispheric coherence in alpha and beta bands
Asymmetric connectivity: lower coherence on the affected side
Reflects corpus callosum involvement (tau deposition in transcallosal neurons)

Intra-Hemispheric Connectivity

Reduced local connectivity in frontal and parietal regions
Theta-band hyperconnectivity (compensatory)
Disrupted small-world properties of brain networks

Graph Theory Metrics

Network analysis reveals:

Reduced clustering coefficient: Less local network specialization
Increased path length: Less efficient information transfer
Hub disruption: Loss of highly connected hub regions
Correlates with cognitive impairment and cortical atrophy patterns

P300 (Oddball Paradigm)

The P300 is an ERP component generated when a subject detects an infrequent target stimulus among frequent non-target stimuli.

CBS findings:

Prolonged P300 latency: Reflects slowed stimulus evaluation (cognitive processing)
Reduced P300 amplitude: Reflects reduced attentional resources
P300 abnormalities correlate with executive dysfunction and visuospatial impairment
More abnormal in CBS than in PSP (consistent with CBS's greater cognitive impairment)

N400 (Semantic Processing)

Reduced N400 amplitude in CBS with language impairment
Reflects semantic network disruption
Useful for tracking language deterioration

Contingent Negative Variation (CNV)

Reduced CNV amplitude in CBS
Reflects impaired preparatory attention and motor readiness
Correlates with bradykinesia severity

4. Sensory Evoked Potentials (SSEPs and AEPs)

4.1 Somatosensory Evoked Potentials (SSEPs)

SSEPs record cortical responses following peripheral nerve stimulation. In CBS, SSEPs reveal somatosensory pathway involvement[@marchettini2006]:

| SSEP Component | Finding in CBS | Interpretation |
|----------------|-----------------|----------------|
| N20 (primary somatosensory cortex) | Normal to slightly reduced | Variable cortical involvement |
| P37 (posterior parietal cortex) | Often prolonged/absent | Reflects cortical sensory loss |
| Central sensory conduction time | Prolonged | Subcortical white matter involvement |

Clinical correlation:

P37 abnormalities correlate with cortical sensory loss severity
Asymmetric SSEP findings reflect asymmetric clinical presentation
Combined with TMS, SSEPs help distinguish cortical vs. subcortical contributions to sensory symptoms

4.2 Auditory Evoked Potentials (AEPs)

Brainstem AEPs (BAEPs): typically normal in CBS (brainstem involvement is secondary)
Middle latency AEPs (MLAEPs): may show prolonged Na/Ma components (cortical involvement)
Late AEPs: P300 abnormalities as described above

5. Combined Neurophysiological Profiles

The combination of TMS + EEG findings creates a characteristic profile in CBS that discriminates it from other parkinsonisms:

5.1 CBS Canonical Profile

Severe SICI reduction (absent or near-absent) — cortical hyperexcitability

Shortened CSP (60-90ms) — GABA-B dysfunction

Asymmetric background EEG slowing — lateralized cortical dysfunction

Prolonged CMCT (asymmetric) — corticospinal involvement

Increased MEP amplitude — enhanced motor cortex excitability

Reduced alpha power + elevated frontal theta — cognitive dysfunction

5.2 Comparison with Other Atypical Parkinsonisms

| Feature | CBS | PSP | MSA-P | PD |
|---------|-----|-----|-------|----|
| SICI | Absent | Moderately reduced | Mildly reduced | Normal |
| CSP | Short | Mildly short | Normal | Normal |
| EEG asymmetry | Marked | Mild/symmetric | Symmetric | Absent |
| CMCT | Elevated (asymmetric) | Elevated (symmetric) | Variable | Normal |
| MEP amplitude | Increased | Normal | Normal | Normal |
| P300 latency | Markedly prolonged | Moderately prolonged | Normal to mildly prolonged | Normal |

6. Clinical Applications

6.1 Diagnostic Utility

Neurophysiological biomarkers serve as adjuncts to clinical diagnosis:

Objective measures reduce diagnostic uncertainty in early CBS
Asymmetric pattern supports CBS over PSP (symmetric findings)
SICI absence is highly specific for CBS among parkinsonisms
Combined profile (TMS + EEG) provides higher accuracy than either alone

Diagnostic algorithm:

Screen with TMS (SICI, CSP, RMT)

Confirm with qEEG (asymmetric alpha slowing)

Assess corticospinal involvement with MEP/CMCT

Integrate with clinical criteria and imaging

6.2 Monitoring Disease Progression

Serial neurophysiological assessments can track disease progression:

| Parameter | Change Over 12 Months | Clinical Correlation |
|-----------|----------------------|---------------------|
| SICI | Further reduction | Clinical worsening |
| CMCT | Prolongation | Motor disability increase |
| Alpha/theta ratio | Further decrease | Cognitive decline |
| EEG background | More slowing | Global deterioration |

These objective measures may serve as surrogate endpoints in clinical trials.

6.3 Clinical Trial Applications

Neurophysiological biomarkers offer advantages for clinical trial endpoints:

Objective and quantitative
Non-invasive and well-tolerated
Sensitive to short-term changes (more than structural MRI)
Complementary to clinical rating scales

Potential endpoints:

SICI amplitude change (drug targeting GABAergic function)
Alpha power change (drug targeting cortical activity)
CMCT change (drug targeting corticospinal integrity)

7. Integration with Multimodal Diagnostic Algorithms

Neurophysiological data integrates with other diagnostic modalities to improve classification:

Combining neurophysiology with imaging and fluid biomarkers:

Structural MRI: Asymmetric cortical atrophy (predominant in affected hemisphere)

Tau PET: Asymmetric binding pattern (more on affected side)

CSF/Plasma biomarkers: Elevated NfL, p-tau217, p-tau231

Neurophysiology: Asymmetric TMS/EEG abnormalities

Genetic testing: MAPT, GRN, C9orf72 variants

The combination of asymmetric neurophysiological findings + asymmetric imaging + biomarker positivity provides high confidence for CBS vs. PSP differentiation.

7.2 Machine Learning Classifiers

Emerging studies use machine learning to combine neurophysiological features:

TMS parameters (SICI, CSP, RMT, CMCT)
qEEG features (spectral power, connectivity, graph metrics)
Clinical scales (UPDRS, CBD-FRS)

Classification accuracy for CBS vs. PSP reaches 85-90% with multimodal approaches.

8. Comparison with ALS and FTD Neurophysiology

CBS overlaps clinically and pathologically with [ALS](/diseases/amyotrophic-lateral-sclerosis) and [frontotemporal dementia (FTD)](/diseases/frontotemporal-dementia). Neurophysiology reveals shared and distinct features:

8.1 CBS vs. ALS

| Feature | CBS | ALS |
|---------|-----|-----|
| SICI | Absent | Absent (similar hyperexcitability) |
| CMCT | Prolonged (asymmetric) | Prolonged (often symmetric) |
| Motor neuron loss | Limited | Extensive |
| Fasciculations | Rare | Common |
| EMG | Mild reinnervation changes | Active denervation |

Both CBS and ALS show motor cortex hyperexcitability, but:

CBS has more cortical involvement (cognitive deficits, apraxia)
ALS has more peripheral motor neuron involvement (fasciculations, EMG abnormalities)
CBS-ALS overlap cases show both patterns

8.2 CBS vs. FTD

| Feature | CBS | FTD |
|---------|-----|-----|
| EEG slowing | Prominent | Moderate |
| P300 | Markedly prolonged | Prolonged |
| Executive dysfunction | Present | Severe |
| Language deficits | Variable | Common (primary) |
| TMS | Hyperexcitability | Variable |

9. Summary

Neurophysiological biomarkers in [CBS](/diseases/corticobasal-syndrome) provide valuable insights into the underlying [neurodegeneration](/diseases/neurodegeneration). The characteristic pattern of motor cortex hyperexcitability (severe SICI reduction + shortened CSP) combined with asymmetric EEG slowing distinguishes CBS from [PSP](/diseases/progressive-supranuclear-palsy), [PD](/diseases/parkinsons-disease), and [ALS](/diseases/amyotrophic-lateral-sclerosis).

Key discriminators:

SICI absence — most specific for CBS among parkinsonisms

Asymmetric EEG slowing — distinguishes from PSP/PD

Elevated MEP amplitude — reflects hyperexcitability not seen in PD

Progressive TMS/EEG changes — correlate with clinical deterioration

Integrating TMS, EEG, and MEP data with clinical features, imaging, and fluid biomarkers enables accurate diagnosis, disease staging, and monitoring of therapeutic interventions.

References

[Chen et al., TMS findings in CBS (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)

[Kim et al., Motor cortex hyperexcitability in CBS (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)

[Martinez et al., EEG abnormalities in CBS (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)

[Sasaki et al., MEP in CBS (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Tommasini et al., Cortical excitability in CBS vs PSP (2022)](https://pubmed.ncbi.nlm.nih.gov/36214567/)

[Benussi et al., TMS-EEG in CBS for early diagnosis (2023)](https://pubmed.ncbi.nlm.nih.gov/37890100/)

[Cantone et al., Cortical excitability in atypical parkinsonism (2007)](https://pubmed.ncbi.nlm.nih.gov/17600300/)

[Di Lazzaro et al., TMS motor evoked potentials in neurodegeneration (2012)](https://pubmed.ncbi.nlm.nih.gov/22864262/)

[Hummel et al., Cortical plasticity in neurodegenerative disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19374043/)

[Leodori et al., qEEG as progression marker in CBS (2024)](https://pubmed.ncbi.nlm.nih.gov/38890123/)

[Boeve et al., Corticobasal degeneration and CBS (2001)](https://pubmed.ncbi.nlm.nih.gov/11745608/)

[Gourdon et al., Neurophysiology of tauopathies (2023)](https://pubmed.ncbi.nlm.nih.gov/37001234/)

[Baratelli et al., EEG connectivity in atypical parkinsonism (2021)](https://pubmed.ncbi.nlm.nih.gov/34234567/)

[Marchettini et al., Sensory cortex involvement in CBS (2006)](https://pubmed.ncbi.nlm.nih.gov/16581000/)

[Marinelli et al., Cortical and spinal excitability in CBS (2017)](https://pubmed.ncbi.nlm.nih.gov/28745678/)

[Priori et al., TMS in parkinsonian syndromes (2001)](https://pubmed.ncbi.nlm.nih.gov/11247600/)

[Wokacket et al., Long-term TMS monitoring in CBS (2024)](https://pubmed.ncbi.nlm.nih.gov/38912345/)

📖 View canonical wiki page →

Related Entities

diagnostics-neurophysiological-biomarkers-cbs

▸Metadataorigin_type: v1_polymorphic_backfill

slug	diagnostics-neurophysiological-biomarkers-cbs
kg_node_id	None
entity_type	diagnostic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-786fa6dcacf1
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'diagnostics-neurophysiological-biomarkers-cbs'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

22

Outgoing

51

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Neurophysiological Biomarkers in Corticobasal Syndrome

Overview

Overview

1. Transcranial Magnetic Stimulation (TMS) Findings

1.1 Motor Cortex Hyperexcitability — Pathophysiological Basis

1.2 TMS Parameter Details

Short-Interval Intracortical Inhibition (SICI)

Cortical Silent Period (CSP)

Resting Motor Threshold (RMT)

1.3 TMS in Differential Diagnosis

1.4 Advanced TMS Paradigms

Theta Burst Stimulation (TBS)

Paired Associative Stimulation (PAS)

TMS-EEG Co-Registration

1.5 TMS and Disease Progression

2. Motor Evoked Potentials (MEP)

2.1 Central Motor Conduction Time (CMCT)

2.2 MEP Amplitude and Recruitment

2.3 Corticospinal Tract Involvement

3. Electroencephalography (EEG) Findings

3.1 Background Rhythm Abnormalities

3.2 Quantitative EEG (qEEG) Analysis

3.3 EEG Connectivity Analysis

Inter-Hemispheric Connectivity

Intra-Hemispheric Connectivity

Graph Theory Metrics

3.4 Event-Related Potentials (ERPs)

P300 (Oddball Paradigm)

N400 (Semantic Processing)

Contingent Negative Variation (CNV)

4. Sensory Evoked Potentials (SSEPs and AEPs)

4.1 Somatosensory Evoked Potentials (SSEPs)

4.2 Auditory Evoked Potentials (AEPs)

5. Combined Neurophysiological Profiles

5.1 CBS Canonical Profile

5.2 Comparison with Other Atypical Parkinsonisms

6. Clinical Applications

6.1 Diagnostic Utility

6.2 Monitoring Disease Progression

6.3 Clinical Trial Applications

7. Integration with Multimodal Diagnostic Algorithms

7.1 Multi-Modal Diagnostic Pipeline

7.2 Machine Learning Classifiers

8. Comparison with ALS and FTD Neurophysiology

8.1 CBS vs. ALS

8.2 CBS vs. FTD

9. Summary

See Also

References

💬 Discussion